Cargando…

Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells

Non-small cell lung cancer (NSCLC) is one of the leading cancer killers. Apigenin (Api) and Naringenin (Nar) are natural bioactive substances obtained in various vegetables and fruits, possessing anti-tumor effects across multiple studies. This study investigated the latent synergistic antiprolifera...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiongxiong, Zhao, Ting, Shi, Zheng, Hu, Cuilan, Li, Qiang, Sun, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343727/
https://www.ncbi.nlm.nih.gov/pubmed/37446609
http://dx.doi.org/10.3390/molecules28134947
_version_ 1785072805299093504
author Liu, Xiongxiong
Zhao, Ting
Shi, Zheng
Hu, Cuilan
Li, Qiang
Sun, Chao
author_facet Liu, Xiongxiong
Zhao, Ting
Shi, Zheng
Hu, Cuilan
Li, Qiang
Sun, Chao
author_sort Liu, Xiongxiong
collection PubMed
description Non-small cell lung cancer (NSCLC) is one of the leading cancer killers. Apigenin (Api) and Naringenin (Nar) are natural bioactive substances obtained in various vegetables and fruits, possessing anti-tumor effects across multiple studies. This study investigated the latent synergistic antiproliferative functions of Api and Nar in A549 and H1299 NSCLC cells. Cell viability was determined after incubating with different concentrations of Api, Nar, or the combination of Api and Nar (CoAN) for 24 h. Analysis using the CompuSyn software revealed that the CI value of each combined dose was < 1, depicting that the two drugs had a synergistic inhibitory effect. The CoAN (A:N = 3:2) group with the lowest CI value was selected for subsequent experiments. The IC(50) of CoAN (A:N = 3:2) was used to determine the cell cycle, the expression ratio of Bax to Bcl2, Caspase 3 activity, and mitochondrial function to assess oxidative stress and apoptosis. The results established that CoAN treatment caused significant cytotoxicity with cell cycle arrest at G2/M phases. Furthermore, CoAN significantly enhanced mitochondria dysfunction, elevated oxidative stress, and activated the apoptotic pathway versus Api or Nar alone groups. Thus, the CoAN chemotherapy approach is promising and deserves further research.
format Online
Article
Text
id pubmed-10343727
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103437272023-07-14 Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells Liu, Xiongxiong Zhao, Ting Shi, Zheng Hu, Cuilan Li, Qiang Sun, Chao Molecules Article Non-small cell lung cancer (NSCLC) is one of the leading cancer killers. Apigenin (Api) and Naringenin (Nar) are natural bioactive substances obtained in various vegetables and fruits, possessing anti-tumor effects across multiple studies. This study investigated the latent synergistic antiproliferative functions of Api and Nar in A549 and H1299 NSCLC cells. Cell viability was determined after incubating with different concentrations of Api, Nar, or the combination of Api and Nar (CoAN) for 24 h. Analysis using the CompuSyn software revealed that the CI value of each combined dose was < 1, depicting that the two drugs had a synergistic inhibitory effect. The CoAN (A:N = 3:2) group with the lowest CI value was selected for subsequent experiments. The IC(50) of CoAN (A:N = 3:2) was used to determine the cell cycle, the expression ratio of Bax to Bcl2, Caspase 3 activity, and mitochondrial function to assess oxidative stress and apoptosis. The results established that CoAN treatment caused significant cytotoxicity with cell cycle arrest at G2/M phases. Furthermore, CoAN significantly enhanced mitochondria dysfunction, elevated oxidative stress, and activated the apoptotic pathway versus Api or Nar alone groups. Thus, the CoAN chemotherapy approach is promising and deserves further research. MDPI 2023-06-23 /pmc/articles/PMC10343727/ /pubmed/37446609 http://dx.doi.org/10.3390/molecules28134947 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Xiongxiong
Zhao, Ting
Shi, Zheng
Hu, Cuilan
Li, Qiang
Sun, Chao
Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells
title Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells
title_full Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells
title_fullStr Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells
title_full_unstemmed Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells
title_short Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells
title_sort synergism antiproliferative effects of apigenin and naringenin in nsclc cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343727/
https://www.ncbi.nlm.nih.gov/pubmed/37446609
http://dx.doi.org/10.3390/molecules28134947
work_keys_str_mv AT liuxiongxiong synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells
AT zhaoting synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells
AT shizheng synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells
AT hucuilan synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells
AT liqiang synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells
AT sunchao synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells